KYSE-30 Cells
USD 395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Información general
| Descripción | KYSE-30 is a well-differentiated human esophageal squamous cell carcinoma (ESCC) cell line derived from a primary tumor in an adult patient. As part of the KYSE series, this cell line was established to study the molecular and cellular characteristics of esophageal cancer. KYSE-30 cells are notable for their rapid proliferation, with a doubling time of 20.8 hours, making them a robust model for in vitro cancer research. These cells grow predominantly as adherent monolayers, displaying a characteristic polygonal shape and uniform appearance under phase-contrast microscopy. Their growth pattern is typical of epithelial-derived cancer cells, forming tightly packed colonies with a tendency to pile up in a disorganized manner, reflecting the invasive nature of the tumor from which they were derived. Genetically, KYSE-30 is significant for its alterations in key tumor suppressor genes. The cell line exhibits a wild-type configuration for the p16 (INK4a) and p15 (INK4b) genes, but it carries a notable point mutation in the p16 gene that results in a premature stop codon, leading to a truncated, non-functional protein. This mutation likely contributes to the loss of cell cycle control, promoting the unchecked proliferation characteristic of cancer cells. The retention of the wild-type p15 gene, however, suggests that p16 gene alterations play a more critical role in the oncogenesis of KYSE-30, which may be relevant in studies focusing on the differential roles of these genes in cancer. KYSE-30 is tumorigenic, as demonstrated by its ability to form tumors when injected into athymic nude mice, making it an excellent model for in vivo studies of ESCC. The histological examination of tumors formed by KYSE-30 cells shows characteristics similar to the original squamous cell carcinoma, providing a faithful representation of the disease. This cell line is invaluable for research into the mechanisms of tumorigenesis, the genetic and epigenetic changes driving esophageal cancer, and the development of targeted therapies, although it is not suitable for therapeutic or in vivo applications. |
|---|---|
| Organismo | Human |
| Tejido | Esophageal Squamous Epithelium |
| Enfermedad | Esophageal squamous cell carcinoma |
| Sinónimos | Kyse-30, KYSE 30, KYSE30, Kyse30, KYSE0030 |
Características
| Edad | 64 years |
|---|---|
| Género | Male |
| Origen étnico | Asian |
| Morfología | Epithelial-Like, With Long Pseudopod |
| Propiedades de crecimiento | Adherent |
Datos normativos
| Referencia | KYSE-30 (Cytion catalog number 305094) |
|---|---|
| Nivel de bioseguridad | 1 |
| NCBI_TaxID | 9606 |
| N.º de acceso de Cellosaurus | CVCL_1351 |
Datos biomoleculares
Manejo
| Medio de cultivo | Please mix Ham's F12 and RPMI 1640 in a 50:50 ratio (Cytion article numbers 820600a and 820702a) |
|---|---|
| Suplementos | Supplement the medium with 10% FBS |
| Reactivo de disociación | Accutase |
| Tiempo de duplicación | 20 to 30 hours |
| Subcultivo | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Renovación de fluidos | 2 to 3 times per week |
| Medio de congelación | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Descongelación y cultivo de células |
|
| Atmósfera de incubación | 37°C, 5% CO2, humidified atmosphere. |
| Condiciones de envío | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Condiciones de almacenamiento | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Control de calidad y análisis molecular
| Esterilidad | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|
Certificado de análisis (CoA)
| Número de lote | Tipo de certificado | Fecha | Número de catálogo |
|---|---|---|---|
| 305094-191023 | Certificado de análisis | 23. May. 2025 | 305094 |
| 305094-270325 | Certificado de análisis | 23. May. 2025 | 305094 |
-
Related products
Related products
KYSE-150 CellsOrganismo Human Tejido Esophagus Enfermedad Esophageal squamous cell carcinoma USD 395.00*KYSE-410 CellsOrganismo Human Tejido Esophagus Enfermedad Esophageal squamous cell carcinoma USD 395.00*